Abstract
The “methionine cycle” plays a critical role in the regulation of concentrations of (S)-adenosylmethionine (AdoMet), the major biological methyl donor. We set out to study sequence variation in genes encoding the enzyme that synthesizes AdoMet in liver, methionine adenosyltransferase 1A (MAT1A) and the major hepatic AdoMet using enzyme, glycine N-methyltransferase (GNMT), as well as functional implications of that variation. We resequenced MAT1A and GNMT using DNA from 288 subjects of three ethnicities, followed by functional genomic and genotype-phenotype correlation studies performed with 268 hepatic biopsy samples. We identified 44 and 42 polymorphisms in MAT1A and GNMT, respectively. Quantitative Western blot analyses for the human liver samples showed large individual variation in MAT1A and GNMT protein expression. Genotype-phenotype correlation identified two genotyped single-nucleotide polymorphisms (SNPs), reference SNP (rs) 9471976 (corrected p = 3.9 × 10−10) and rs11752813 (corrected p = 1.8 × 10−5), and 42 imputed SNPs surrounding GNMT that were significantly associated with hepatic GNMT protein levels (corrected p values < 0.01). Reporter gene studies showed that variant alleles for both genotyped SNPs resulted in decreased transcriptional activity. Correlation analyses among hepatic protein levels for methionine cycle enzymes showed significant correlations between GNMT and MAT1A (p = 1.5 × 10−3) and between GNMT and betaine homocysteine methyltransferase (p = 1.6 × 10−7). Our discovery of SNPs that are highly associated with hepatic GNMT protein expression as well as the “coordinate regulation” of methionine cycle enzyme protein levels provide novel insight into the regulation of this important human liver biochemical pathway.
Footnotes
This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grants R01-GM28157, U19-GM61388 (The Pharmacogenomics Research Network), R21-GM86689]; the National Institutes of Health National Cancer Institute [Grant R01-CA132780]; the National Institutes of Health National Center for Research Resources [Grant KL2-RR024151] (KL2 Mentored Career Development Award); a Gerstner Family Mayo Career Development Award in Individualized Medicine; and a PhRMA Foundation Center of Excellence Award in Clinical Pharmacology.
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
↵
The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material.
ABBREVIATIONS:
- AdoMet
- (S)-adenosylmethionine
- MAT
- methionine adenosyltransferase
- AdoHcy
- (S)-adenosylhomocysteine
- GNMT
- glycine N-methyltransferase
- BHMT
- betaine homocysteine methyltransferase
- EA
- European American
- AA
- African American
- HCA
- Han Chinese American
- SNP
- single-nucleotide polymorphism
- rs
- reference SNP
- kb
- kilobase
- FR
- flanking region
- PCR
- polymerase chain reaction
- WT
- wild type
- LD
- linkage disequilibrium
- bp
- base pair
- qRT-PCR
- quantitative reverse transcriptase-PCR
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
- ns
- nonsynonymous
- SHMT1
- serine hydroxymethyltransferase 1
- COMT
- catechol-O-methyltransferase.
- Received May 26, 2012.
- Accepted July 17, 2012.
- Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|